Tania Small, SVP, Head of Medical Affairs at Bristol Myers Squibb, shared a post on LinkedIn:
“At Bristol Myers Squibb, we’ve never stopped investigating multiple myeloma.
The human cost of this disease is undeniable. Mariska Hargitay lost her father to it 20 years ago. And while much has changed since then, the pain of that loss and the urgency to keep pushing forward, has not.
These realities are what drive our science.
We have our best researchers on the case – investigating new approaches like CELMoD research and working to challenge the very biology of myeloma. Mariska’s story – and so many like hers – keeps us going.
For every patient and family, hope means the investigation never stops.
See what we’re looking into: InvestigatingMyeloma.com.”
Other articles about Multiple Myeloma on OncoDaily.